Gianmarco Bellucci | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach	MULTIPLE SCLEROSIS	2024
Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report	NEUROLOGICAL SCIENCES	2024
Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observation	MULTIPLE SCLEROSIS AND RELATED DISORDERS	2023
Blurred lines: bilateral optic perineuritis mimicking idiopathic intracranial hypertension	NEUROLOGICAL SCIENCES	2023
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review	FRONTIERS IN IMMUNOLOGY	2023
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study	MULTIPLE SCLEROSIS	2022
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome	SCIENTIFIC REPORTS	2022
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS	FRONTIERS IN NEUROLOGY	2022
Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease	BioRxiv	2022
Leukocyte telomere length variability as a potential biomarker in patients with polyQ diseases	ANTIOXIDANTS	2022
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review	FRONTIERS IN NEUROLOGY	2022
Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease: A Pilot Study	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Mait cells and microbiota in multiple sclerosis and other autoimmune diseases	MICROORGANISMS	2021
A case of double standard. Sex differences in multiple sclerosis risk factors	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2021
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?	FRONTIERS IN IMMUNOLOGY	2021
Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint	CURRENT NEUROPHARMACOLOGY	2021
ADEM after ChAdOx1 nCoV-19 vaccine: A case report	MULTIPLE SCLEROSIS	2021
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies	EBIOMEDICINE	2021
Enrichment analysis of GWAS data in autoimmunity delineates the multiple sclerosis-Epstein Barr virus association	BioRxiv	2021